Cargando…
The proteoglycan repertoire of lymphoid cells
Proteoglycans have been studied to a limited extent in lymphoid cells. In this study we have investigated the expression of proteoglycans in B-cells, CD4+ T-cells, CD8+ T-cells, natural killer cells, as well as in nine different cell lines established from patients with lymphoid malignancies. Sergly...
Autores principales: | Fadnes, Bodil, Husebekk, Anne, Svineng, Gunbjørg, Rekdal, Øystein, Yanagishita, Masaki, Kolset, Svein O., Uhlin-Hansen, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433671/ https://www.ncbi.nlm.nih.gov/pubmed/22777011 http://dx.doi.org/10.1007/s10719-012-9427-9 |
Ejemplares similares
-
The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells
por: Fadnes, Bodil, et al.
Publicado: (2009) -
Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
por: Fadnes, Bodil, et al.
Publicado: (2011) -
Urokinase Plasminogen Activator Receptor (uPAR) and Plasminogen Activator Inhibitor-1 (PAI-1) Are Potential Predictive Biomarkers in Early Stage Oral Squamous Cell Carcinomas (OSCC)
por: Magnussen, Synnøve, et al.
Publicado: (2014) -
Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma
por: Rikardsen, Oddveig G., et al.
Publicado: (2015) -
Editorial: Growth and Tissue Regeneration with focus on Proteoglycans
por: Pedersen, Mona Elisabeth, et al.
Publicado: (2023)